Blood loss is the leading cause of death in trauma patients between the ages of 1 and 46 years, largely because they cannot ...

In patients experiencing excessive bleeding during cardiac surgery, a concentrated blood product containing proteins that ...

Despite a haemophilia market bustling with rivals, Qfitlia’s broad label and favourable dosing regimen could give it an upper ...

Qfitlia (fitusiran), an siRNA drug to treat the frequency of bleeding episodes in adult and pediatric patients with hemophilia A or B, gets FDA approval.

As scientists, we often think we understand a virus—its structure, its tricks, the way it moves through the body. But every ...